Aflac Incorporated (NYSE:AFL) Position Boosted by Matrix Trust Co

Matrix Trust Co boosted its position in Aflac Incorporated (NYSE:AFL) by 2.2% in the fourth quarter, HoldingsChannel.com reports. The firm owned 21,480 shares of the financial services provider’s stock after purchasing an additional 465 shares during the quarter. Matrix Trust Co’s holdings in Aflac were worth $1,772,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Fortitude Family Office LLC acquired a new stake in Aflac in the fourth quarter worth approximately $25,000. Bruce G. Allen Investments LLC acquired a new stake in Aflac in the fourth quarter worth approximately $32,000. Impact Partnership Wealth LLC lifted its position in Aflac by 471.4% in the third quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 330 shares during the period. Criterion Capital Advisors LLC acquired a new stake in Aflac in the fourth quarter worth approximately $33,000. Finally, Arlington Trust Co LLC acquired a new stake in shares of Aflac during the 4th quarter valued at $35,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Aflac Stock Down 0.1 %

Shares of AFL traded down $0.12 during mid-day trading on Friday, reaching $83.61. The company’s stock had a trading volume of 1,839,028 shares, compared to its average volume of 2,169,786. Aflac Incorporated has a 1 year low of $64.10 and a 1 year high of $86.26. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33. The company has a market cap of $48.11 billion, a price-to-earnings ratio of 10.78, a price-to-earnings-growth ratio of 2.30 and a beta of 0.91. The business has a fifty day moving average of $82.69 and a 200 day moving average of $81.75.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a return on equity of 17.59% and a net margin of 24.92%. The company had revenue of $3.78 billion during the quarter, compared to analyst estimates of $4.44 billion. During the same period last year, the company posted $1.29 earnings per share. As a group, analysts forecast that Aflac Incorporated will post 6.41 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Piper Sandler increased their price objective on Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Friday, April 5th. Raymond James increased their price objective on Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a research report on Friday, February 2nd. StockNews.com downgraded Aflac from a “hold” rating to a “sell” rating in a research report on Wednesday, April 10th. Wells Fargo & Company cut their price objective on Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a research report on Thursday, April 11th. Finally, Keefe, Bruyette & Woods increased their price objective on Aflac from $83.00 to $87.00 and gave the company a “market perform” rating in a research report on Wednesday, April 10th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Aflac has an average rating of “Hold” and a consensus price target of $82.15.

Insider Transactions at Aflac

In other news, Director Thomas J. Kenny sold 5,000 shares of the company’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the transaction, the director now directly owns 17,920 shares of the company’s stock, valued at $1,516,390.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Aflac news, Director Masatoshi Koide sold 30,493 shares of the stock in a transaction on Friday, February 16th. The shares were sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the transaction, the director now directly owns 86,090 shares of the company’s stock, valued at $6,879,451.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Thomas J. Kenny sold 5,000 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the transaction, the director now directly owns 17,920 shares in the company, valued at $1,516,390.40. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 46,493 shares of company stock valued at $3,765,706. 0.90% of the stock is owned by insiders.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.